Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review.
- DOI
- 10.3389/fonc.2026.1800705
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1800705,
title = {Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review.},
author = {Cleanclay WD and Kintung IF and Kernyuy FB and Yensii NG and Fagbohun BO and Amadi EC and Kaze NN},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1800705},
url = {https://doi.org/10.3389/fonc.2026.1800705}
}RIS
TY - JOUR TI - Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review. AU - Cleanclay WD AU - Kintung IF AU - Kernyuy FB AU - Yensii NG AU - Fagbohun BO AU - Amadi EC AU - Kaze NN PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1800705 UR - https://doi.org/10.3389/fonc.2026.1800705 ER -
APA
WD, C., IF, K., FB, K., NG, Y., BO, F., EC, A., & NN, K. (2026). Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1800705
Source records
- pubmed · retrieved 2026-09-25T13:47:19.350Z